Logo image of DSM.AS

Koninklijke DSM NV (DSM.AS) Stock Earnings & Estimates

AMS:DSM - NL0000009827 - Common Stock

114.05 EUR
+0.15 (+0.13%)
Last: 5/30/2023, 7:00:00 PM

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030
Revenue
YoY % growth
DSM.AS revenue by date.DSM.AS revenue by date.
8.106B
1.35%		7.269B
-10.33%		8.39B
15.42%		10.011B
19.32%		10.759B
7.47%		11.219B
4.28%		10.302B
-8.17%		10.871B
5.52%		11.467B
5.48%		12.091B
5.44%		12.749B
5.44%
EBITDA
YoY % growth
DSM.AS ebitda by date.DSM.AS ebitda by date.
1.468B
-0.14%		1.405B
-4.29%		1.315B
-6.41%		1.544B
17.41%		1.809B
17.16%		2.013B
11.28%		2.059B
2.29%		2.09B
1.51%		2.188B
4.69%		2.318B
5.94%		2.426B
4.66%
EBIT
YoY % growth
DSM.AS ebit by date.DSM.AS ebit by date.
728M
-13.13%		724M
-0.55%		663M
-8.43%		810.33M
22.22%		998.02M
23.16%		1.16B
16.23%		1.282B
10.52%		1.354B
5.62%		1.429B
5.54%		1.533B
7.28%		1.613B
5.22%
Operating Margin
DSM.AS operating margin by date.DSM.AS operating margin by date.
8.98%9.96%7.90%8.09%9.28%10.34%12.44%12.46%12.46%12.68%12.65%
EPS
YoY % growth
DSM.AS eps by date.DSM.AS eps by date.
4.29
-7.34%		N/A
20.70%		N/A
-19.13%		3.44
-17.84%		4.17
21.25%		4.77
14.35%		5.86
22.86%		6.25
6.56%		6.64
6.32%		7.21
8.54%		7.64
6.04%

All data in EUR

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q1 / 23 Q2 / 23 Q3 / 23 Q4 / 23 Q1 / 24
EPS
Q2Q % growth		0.47
-63.05%		0.95
-4.49%		0.51
-49.11%		1.12
-12.37%		0.95
100.85%
Revenue
Q2Q % growth		2.053B
-16.92%		2.105B
-48.85%		2.23B
1.59%		2.171B
-49.22%		2.156B
5.02%
EBITDA
Q2Q % growth		283.05M
-39.49%		334.82M
-27.22%		383.8M
1.30%		367.14M
20.30%		N/A
EBIT
Q2Q % growth		135.57M
-53.43%		152.57M
-61.67%		93.739M
-63.65%		194.44M
-31.54%		222.42M
64.06%

All data in EUR

Recent Earnings VS Estimates Surprises (EUR)
PeriodReportedEstimateDifferenceSurprise
Q4 2022
Q2Q % growth
3.38%		1.28%
Q3 2022
Q2Q % growth
-20.59%		1.00%
Q2 2022
Q2Q % growth
-25.66%		1.00%
Q1 2022
Q2Q % growth
5.12%		1.28%
Q4 2021
Q2Q % growth
26.51%		1.24%
Q3 2021
Q2Q % growth
25.30%		1.27%
Q2 2021
Q2Q % growth
26.89%		1.34%
Q1 2021
Q2Q % growth
-1.86%		1.22%
Q4 2020
Q2Q % growth		 0.98
3.16%		1.04-0.06-5.68%
Q3 2020
Q2Q % growth		 1.01
-25.74%		1.03-0.02-2.09%
Q2 2020
Q2Q % growth		 1.06
-11.67%		1.07-0.01-0.73%
Q1 2020
Q2Q % growth		 1.24
10.71%		1.060.1816.97%
Q4 2019
Q2Q % growth		 0.95 1.08-0.13-12.18%
Q3 2019
Q2Q % growth		 1.36 1.220.1411.87%
Q2 2019
Q2Q % growth		 1.20 1.29-0.09-6.92%
Q1 2019
Q2Q % growth		 1.12 1.17-0.05-4.14%
DSM.AS Yearly EPS VS EstimatesDSM.AS Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2 4 6
Recent Revenue VS Estimates Surprises (EUR)
PeriodReportedEstimateDifferenceSurprise
Q4 2022
Q2Q % growth		 4.275B
13.94%		2.165B2.11B97.46%
Q3 2022
Q2Q % growth
0.18%		2.195B%
Q2 2022
Q2Q % growth		 4.115B
17.00%		2.448B1.667B68.10%
Q1 2022
Q2Q % growth
14.66%		2.471B%
Q4 2021
Q2Q % growth		 3.752B
80.38%		2.33B1.422B61.03%
Q3 2021
Q2Q % growth
11.73%		2.191B%
Q2 2021
Q2Q % growth		 3.517B
98.48%		2.286B1.231B53.85%
Q1 2021
Q2Q % growth
-6.02%		2.155B%
Q4 2020
Q2Q % growth		 2.08B
7.55%		2.171B-91M-4.19%
Q3 2020
Q2Q % growth		 1.961B
-3.64%		2.222B-261M-11.75%
Q2 2020
Q2Q % growth		 1.772B
-22.14%		2.169B-397M-18.30%
Q1 2020
Q2Q % growth		 2.293B
0.04%		2.265B28M1.24%
Q4 2019
Q2Q % growth		 1.934B 2.268B-334M-14.73%
Q3 2019
Q2Q % growth		 2.035B 2.316B-281M-12.13%
Q2 2019
Q2Q % growth		 2.276B 2.344B-68M-2.90%
Q1 2019
Q2Q % growth		 2.292B 2.294B-2M-0.09%
DSM.AS Yearly Revenue VS EstimatesDSM.AS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2B 4B 6B 8B 10B
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0% -16.28% 0% -10.83%
Revenue0% 0.2% 0% -1.4%